Conclusively, our data demonstrate the therapeutic potential of p62-engineered Lactobacilli in an AD mouse model and propose a novel multi-target approach for AD treatment that takes advantage of the multifunctional activity of the p62 protein and of the beneficial properties and safety of these food grade bacteria. Here, SQSTM1 is linked to Alzheimer disease.